Literature DB >> 15015635

Expression of P53, P21 in human lung adenocarcinoma A549 cell strains under hypoxia conditions and the effect of TSA on their expression.

Hong Huang1, Zhenxiang Zhang, Yongjian Xu, Jingfang Shao.   

Abstract

This paper was designed to investigate the expression of p53, p21 of A549 cell strains under hypoxic condition and the effect of trichostatin A (TSA), the inhibitor of histone deacetylasel (HDAC1) on their expression. The authors designed 1 normoxia group (control group) and 6 hypoxia groups (experimental group): hypoxia 6 h group (A), TSA+hypoxia 6 h (B), hypoxia 12 h group (C), hypoxia 24 h group (D), TSA+hypoxia 24 h (E), hypoxia 48 h group (F). The expression of HDAC1 in A549 cells was examined by using Western blot and the expression of p53, p21 in A549 cells and the effect of TSA on them were determined by using immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR). The A value expressed by HDAC1 in A549 cell strains was 138+/-11 in the control group, 78+/-4, 86+/-5, 124+/-3, 120+/-9 in experimental groups A, C, D, F, respectively. The A value of the expression of the protein and mRNA of p53 in A549 cell strains were 0.12+/-0.02, 0.62+/-0.02 in the control group, 0.10+/-0.03, 0.32 +/-0.03; 0.11+/-0.01, 0.33+/-0.02; 0.13+/-0.03, 0.58+/-0.01; 0.12+/-0.02, 0.56+/-0.02 in experimental group A, B, D, E, respectively. The A value of the expression of the protein and mRNA of p21 in A549 cell strains were 0.17+/-0.03, 0.62+/-0.03 in the control group, 0.16+/-0.02, 0.50+/-0.02; 0.14+/-0.02, 0.36+/-0.02; 0.15+/-0.03, 0.49+/-0.03; 0.13+/-0.02, 0.33+/-0.02 in experimental groups A, B, D, E, respectively. These results indicate that the expression of HDAC1 is regulated by hypoxia and the effect of TSA is closely related to the expression of P21 under hypoxia condition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15015635     DOI: 10.1007/BF02829417

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

Authors:  R Ravi; B Mookerjee; Z M Bhujwalla; C H Sutter; D Artemov; Q Zeng; L E Dillehay; A Madan; G L Semenza; A Bedi
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

2.  Chemopreventive efficacy of suberoylanilide hydroxamic acid (SAHA) against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice.

Authors:  Dhimant Desai; Arunangshu Das; Leonard Cohen; Karam el-Bayoumy; Shantu Amin
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

3.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

Authors:  J A Forsythe; B H Jiang; N V Iyer; F Agani; S W Leung; R D Koos; G L Semenza
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.

Authors:  M S Kim; H J Kwon; Y M Lee; J H Baek; J E Jang; S W Lee; E J Moon; H S Kim; S K Lee; H Y Chung; C W Kim; K W Kim
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

5.  Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.

Authors:  Junji Tsurutani; Hiroshi Soda; Mikio Oka; Mitsuhiro Suenaga; Seiji Doi; Yoichi Nakamura; Katsumi Nakatomi; Ken Shiozawa; Yasuaki Y Amada; Shimeru Kamihira; Shigeru Kohno
Journal:  Int J Cancer       Date:  2003-03-20       Impact factor: 7.396

6.  Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.

Authors:  G Fontanini; L Boldrini; S Chinè; F Pisaturo; F Basolo; A Calcinai; M Lucchi; A Mussi; C A Angeletti; G Bevilacqua
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  6 in total
  1 in total

1.  Effect of histone deacetylase on prostate carcinoma.

Authors:  Yuanfeng Zhang; Qingchun Xu; Guoyuan Liu; Hong Huang; Weiqiang Lin; Yueying Huang; Zepai Chi; Shaochuan Chen; Kaijian Lan; Jiahua Lin; Yonghai Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.